Clinical Trial Update: Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated omega-3 fatty acid for joint symptoms in breast cancer patients treated with aromatase inhibitors; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Omega-3 Fatty Acid (omega-3 fatty acids)

Snippet

Sponsor: Columbia University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED